Publications Le 07 Déc 2020 Publications Filtrer nos publications par : Année202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001 2018 Amyloid "accumulators": The next generation of candidates for amyloid-targeted clinical trials? Consulter 2018 Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. We investigated whether amyloid-β (Aβ) and tau affected cognition in cognitively normal (CN) individuals, and whether norms for neuropsychological tests (…) Consulter 2018 Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer’s disease. Alzheimer’s disease (AD) is characterized by the presence of β-amyloid (Aβ) deposition and neurodegeneration. To seek for signs of such (…) Consulter 2018 Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds. Our aim is to validate the process steps implemented by the French CATI platform to assess amyloid status, obtained from (…) Consulter 2018 Multimodal Neuroimaging in Alzheimer’s Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle. Over the last ten years, we have conducted research in Alzheimer’s disease (AD) using multimodal neuroimaging techniques to improve diagnosis, (…) Consulter 2018 Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer’s disease. Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer’s disease (AD), but its prevalence is unclear because (…) Consulter Pages: 12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091Load More Retour
